Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2021 Volume 24 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2021 Volume 24 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury

Corrigendum in: /10.3892/mmr.2022.12757
  • Authors:
    • Jinshi Zhang
    • Wenfang He
    • Danna Zheng
    • Qiang He
    • Mingming Tan
    • Juan Jin
  • View Affiliations / Copyright

    Affiliations: Department of Nephrology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Department of Quality Management, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 795
    |
    Published online on: September 13, 2021
       https://doi.org/10.3892/mmr.2021.12435
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute kidney injury (AKI) poses a severe threat to human health. MicroRNAs (miRNAs/miRs) are known to be involved in the progression of AKI; however, the function of miR‑1184 in AKI remains unclear. Thus, the aim of the present study was to examine the role of this miRNA in kidney injury. In order to mimic AKI in vitro, HK‑2 cells were treated with cisplatin. Bioinformatics analysis was performed to explore the differentially expressed miRNAs in AKI. A Cell Counting Kit‑8 assay and flow cytometry were performed to examine cell viability and apoptosis, respectively. mRNA expression levels were detected via reverse transcription‑quantitative PCR, and protein levels were investigated by western blot analysis. ELISA was performed to examine the levels of IL‑1β and TNF‑α in the cell supernatants. The results revealed that miR‑1184 expression was downregulated in AKI. Exosomes derived from miR‑1184 agomir‑treated mesenchymal stem cells (MSCs) significantly reversed cisplatin‑induced cell growth inhibition by inhibiting apoptosis. Moreover, forkhead box O4 (FOXO4) was found to be the direct target of miR‑1184, and exosomes expressing miR‑1184 notably inhibited cisplatin‑induced inflammatory responses in HK‑2 cells via the mediation of IL‑1β and TNF‑α. Furthermore, exosomes derived from miR‑1184 agomir‑treated MSCs significantly induced G1 phase arrest in HK‑2 cells via the regulation of FOXO4, p27 Kip1 and CDK2. In conclusion, the present study demonstrated that exosomal‑miR‑1184 derived from MSCs alleviates cisplatin‑associated AKI. Thus, the findings presented herein may shed new light onto the exploration of novel strategies for the treatment of AKI.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Stephen Inbaraj B and Chen BH: An overview on recent in vivo biological application of cerium oxide nanoparticles. Asian J Pharm Sci. 15:558–575. 2020. View Article : Google Scholar : PubMed/NCBI

2 

Zhang J, Healy HG, Baboolal K, Wang Z, Venuthurupalli SK, Tan KS, Cameron A and Hoy WE; CKD.QLD Collaborative, : Frequency and consequences of acute kidney injury in patients with CKD: A registry study in queensland australia. Kidney Med. 1:180–190. 2019. View Article : Google Scholar : PubMed/NCBI

3 

Guillemet L, Jamme M, Bougouin W, Geri G, Deye N, Vivien B, Varenne O, Pène F, Mira JP, Barat F, et al: Effects of early high-dose erythropoietin on acute kidney injury following cardiac arrest: Exploratory post hoc analyses from an open-label randomized trial. Clin Kidney J. 13:413–420. 2020.PubMed/NCBI

4 

Güzel C, Yeşiltaş S, Daşkaya H, Uysal H, Sümer I and Türkay M: The effect of gender on acute kidney injury developing in the intensive care unit. Hippokratia. 23:126–130. 2019.PubMed/NCBI

5 

Xiong J, Zhang M, Guo X, Pu L, Xiong H, Xiang P, Liu J and Li A: Acute kidney injury in critically ill cirrhotic patients with spontaneous bacterial peritonitis: A comparison of KDIGO and ICA criteria. Arch Med Sci. 16:569–576. 2020. View Article : Google Scholar : PubMed/NCBI

6 

Deng J, Tan W, Luo Q, Lin L, Zheng L and Yang J: Long non-coding RNA MEG3 promotes renal tubular epithelial cell pyroptosis by regulating the miR-18a-3p/GSDMD pathway in lipopolysaccharide-induced acute kidney injury. Front Physiol. 12:6632162021. View Article : Google Scholar : PubMed/NCBI

7 

Han D, Fang R, Shi R, Jin Y and Wang Q: LncRNA NKILA knockdown promotes cell viability and represses cell apoptosis, autophagy and inflammation in lipopolysaccharide-induced sepsis model by regulating miR-140-5p/CLDN2 axis. Biochem Biophys Res Commun. 559:8–14. 2021. View Article : Google Scholar : PubMed/NCBI

8 

Yang J, Wu L, Liu S, Hu X, Wang Q and Fang L: Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis. Med Microbiol Immunol. 210:121–132. 2021. View Article : Google Scholar : PubMed/NCBI

9 

Xu Y, Qin S, Niu Y, Gong T, Zhang Z and Fu Y: Effect of fluid shear stress on the internalization of kidney-targeted delivery systems in renal tubular epithelial cells. Acta Pharm Sin B. 10:680–692. 2020. View Article : Google Scholar : PubMed/NCBI

10 

Guthrie GD and Bell S: Deprivation and kidney disease-a predictor of poor outcomes. Clin Kidney J. 13:128–132. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Jia X, Wei L and Zhang Z: NEAT1 Overexpression indicates a poor prognosis and induces chemotherapy resistance via the miR-491-5p/SOX3 signaling pathway in ovarian cancer. Front Genet. 12:6162202021. View Article : Google Scholar : PubMed/NCBI

12 

Zhang F, Sang Y, Chen D, Wu X, Wang X, Yang W and Chen Y: M2 macrophage-derived exosomal long non-coding RNA AGAP2-AS1 enhances radiotherapy immunity in lung cancer by reducing microRNA-296 and elevating NOTCH2. Cell Death Dis. 12:4672021. View Article : Google Scholar : PubMed/NCBI

13 

Wang Q, Tao Y, Xie H, Liu C and Liu P: MicroRNA-101 inhibits renal tubular epithelial-to-mesenchymal transition by targeting TGF-β1 type I receptor. Int J Mol Med. 47:1192021. View Article : Google Scholar : PubMed/NCBI

14 

Cao JY, Wang B, Tang TT, Wen Y, Li ZL, Feng ST, Wu M, Liu D, Yin D, Ma KL, et al: Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics. 11:5248–5266. 2021. View Article : Google Scholar : PubMed/NCBI

15 

Scullion KM, Vliegenthart ADB, Rivoli L, Oosthuyzen W, Farrah TE, Czopek A, Webb DJ, Hunter RW, Bailey MA, Dhaun N and Dear JW: Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease. iScience. 24:1019372020. View Article : Google Scholar : PubMed/NCBI

16 

Sun B, Qu Z, Cheng GL, Yang YW, Miao YF, Chen XG, Zhou XB and Li B: Urinary microRNAs miR-15b and miR-30a as novel noninvasive biomarkers for gentamicin-induced acute kidney injury. Toxicol Lett. 338:105–113. 2021. View Article : Google Scholar : PubMed/NCBI

17 

Jeon BS, Lee SH, Hwang SR, Yi H, Bang JH, Tham NTT, Lee HK, Woo GH, Kang HG and Ku HO: Identification of urinary microRNA biomarkers for in vivo gentamicin-induced nephrotoxicity models. J Vet Sci. 21:e812020. View Article : Google Scholar : PubMed/NCBI

18 

Pan T, Jia P, Chen N, Fang Y, Liang Y, Guo M and Ding X: Delayed remote ischemic preconditioning confersrenoprotection against septic acute kidney injury via exosomal miR-21. Theranostics. 9:405–423. 2019. View Article : Google Scholar : PubMed/NCBI

19 

Jiang L, Liu XQ, Ma Q, Yang Q, Gao L, Li HD, Wang JN, Wei B, Wen J, Li J, et al: hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells. FASEB J. 33:3523–3535. 2019. View Article : Google Scholar : PubMed/NCBI

20 

Zhang X, Wang N, Huang Y, Li Y, Li G, Lin Y, Atala AJ, Hou J and Zhao W: Extracellular vesicles from three dimensional culture of human placental mesenchymal stem cells ameliorated renal ischemia/reperfusion injury. Int J Artif Organs. Jan 19–2021.(Epub ahead of print). doi: 10.1177/0391398820986809. View Article : Google Scholar

21 

Jiang Z, Hou Z, Li L, Liu W, Yu Z and Chen S: Exosomal circEPB41L2 serves as a sponge for miR-21-5p and miR-942-5p to suppress colorectal cancer progression by regulating the PTEN/AKT signalling pathway. Eur J Clin Invest. 51:e135812021. View Article : Google Scholar : PubMed/NCBI

22 

Pineles B, Mani A, Sura L, Rossignol C, Albayram M, Weiss MD and Goetzl L: Neuronal exosome proteins: Novel biomarkers for predicting neonatal response to therapeutic hypothermia. Arch Dis Child Fetal Neonatal Ed. May 21–2021.(Epub ahead of print). doi: 10.1136/archdischild-2020-321096. View Article : Google Scholar : PubMed/NCBI

23 

Zhang Y, Huang H, Liu W, Liu S, Wang XY, Diao ZL, Zhang AH, Guo W, Han X, Dong X and Katilov O: Endothelial progenitor cells-derived exosomal microRNA-21-5p alleviates sepsis-induced acute kidney injury by inhibiting RUNX1 expression. Cell Death Dis. 12:3352021. View Article : Google Scholar : PubMed/NCBI

24 

Huang Y, He Y, Makarcyzk MJ and Lin H: Senolytic peptide FOXO4-DRI selectively removes senescent cells from in vitro expanded human chondrocytes. Front Bioeng Biotechnol. 9:6775762021. View Article : Google Scholar : PubMed/NCBI

25 

Ji C, Zhang J, Zhou Z, Shi H, Liu W, Sun F, Zhang C, Zhang L, Sun Z and Qian H: Platelet-rich plasma promotes MSCs exosomes paracrine to repair acute kidney injury via AKT/Rab27 pathway. Am J Transl Res. 13:1445–1457. 2021.PubMed/NCBI

26 

Cao J, Wang B, Tang T, Lv L, Ding Z, Li Z, Hu R, Wei Q, Shen A, Fu Y and Liu B: Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury. Stem Cell Res Ther. 11:2062020. View Article : Google Scholar : PubMed/NCBI

27 

McSweeney KR, Gadanec LK, Qaradakhi T, Ali BA, Zulli A and Apostolopoulos V: Mechanisms of cisplatin-induced acute kidney injury: Pathological mechanisms, pharmacological interventions, and genetic mitigations. Cancers (Basel). 13:15722021. View Article : Google Scholar : PubMed/NCBI

28 

Cheng Q and Wang L: LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p. Cell Cycle. 19:290–299. 2020. View Article : Google Scholar : PubMed/NCBI

29 

Varet H, Brillet-Guéguen L, Coppée JY and Dillies MA: SARTools: A DESeq2- and EdgeR-based R pipeline for comprehensive differential analysis of RNA-Seq data. PLoS One. 11:e01570222016. View Article : Google Scholar : PubMed/NCBI

30 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

31 

Ren GL, Zhu J, Li J and Meng XM: Noncoding RNAs in acute kidney injury. J Cell Physiol. 234:2266–2276. 2019. View Article : Google Scholar : PubMed/NCBI

32 

Zhang W, Zhou X, Zhang H, Yao Q, Liu Y and Dong Z: Extracellular vesicles in diagnosis and therapy of kidney diseases. Am J Physiol Renal Physiol. 311:F844–F851. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Wang X, Chen Y, Liu W, Liu T and Sun D: Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling. J Cell Mol Med. 24:9908–9924. 2020. View Article : Google Scholar : PubMed/NCBI

34 

Chen S, Wang Y, Xu M, Zhang L, Su Y, Wang B and Zhang X: miR-1184 regulates the proliferation and apoptosis of colon cancer cells via targeting CSNK2A1. Mol Cell Probes. 53:1016252020. View Article : Google Scholar : PubMed/NCBI

35 

Alzahrani FA: Melatonin improves therapeutic potential of mesenchymal stem cells-derived exosomes against renal ischemia-reperfusion injury in rats. Am J Transl Res. 11:2887–2907. 2019.PubMed/NCBI

36 

Shin JH, Shin DH and Kim JS: Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells. Asian J Pharm Sci. 15:472–481. 2020. View Article : Google Scholar : PubMed/NCBI

37 

Zhang D, Liu K, Hu W, Lu X, Li L, Zhang Q, Huang H and Wang H: Prenatal dexamethasone exposure caused fetal rats liver dysplasia by inhibiting autophagy-mediated cell proliferation. Toxicology. 449:1526642021. View Article : Google Scholar : PubMed/NCBI

38 

Henriques J and Lindorff-Larsen K: Protein dynamics enables phosphorylation of buried residues in Cdk2/cyclin-A-bound p27. Biophys J. 119:2010–2018. 2020. View Article : Google Scholar : PubMed/NCBI

39 

Park JW, Cho JW, Joo SY, Kim CS, Choi JS, Bae EH, Ma SK, Kim SH, Lee J and Kim SW: Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation. Eur J Pharmacol. 683:301–309. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Coombes JD, Mreich E, Liddle C and Rangan GK: Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy. Kidney Int. 68:2599–2607. 2005. View Article : Google Scholar : PubMed/NCBI

41 

Guerra B, Dembic M, Siddiqui MA, Dominguez I, Ceppi P and Andresen BS: Down-regulation of CK2α leads to up-regulation of the cyclin-dependent kinase inhibitor p27KIP1 in conditions unfavorable for the growth of myoblast cells. Cell Physiol Biochem. 54:1177–1198. 2020. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang J, He W, Zheng D, He Q, Tan M and Jin J: Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury Corrigendum in /10.3892/mmr.2022.12757. Mol Med Rep 24: 795, 2021.
APA
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., & Jin, J. (2021). Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury Corrigendum in /10.3892/mmr.2022.12757. Molecular Medicine Reports, 24, 795. https://doi.org/10.3892/mmr.2021.12435
MLA
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., Jin, J."Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury Corrigendum in /10.3892/mmr.2022.12757". Molecular Medicine Reports 24.5 (2021): 795.
Chicago
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., Jin, J."Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury Corrigendum in /10.3892/mmr.2022.12757". Molecular Medicine Reports 24, no. 5 (2021): 795. https://doi.org/10.3892/mmr.2021.12435
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, He W, Zheng D, He Q, Tan M and Jin J: Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury Corrigendum in /10.3892/mmr.2022.12757. Mol Med Rep 24: 795, 2021.
APA
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., & Jin, J. (2021). Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury Corrigendum in /10.3892/mmr.2022.12757. Molecular Medicine Reports, 24, 795. https://doi.org/10.3892/mmr.2021.12435
MLA
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., Jin, J."Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury Corrigendum in /10.3892/mmr.2022.12757". Molecular Medicine Reports 24.5 (2021): 795.
Chicago
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., Jin, J."Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury Corrigendum in /10.3892/mmr.2022.12757". Molecular Medicine Reports 24, no. 5 (2021): 795. https://doi.org/10.3892/mmr.2021.12435
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team